A trend of psychedelics being used to improve focus, creativity and general well-being at work is on the rise, especially among a growing group of Silicon Valley entrepreneurs and employees. And, it seems like a last year's warning from the U.S. Food and Drug Administration (FDA) about potential risks associated with compounded ketamine products, including oral formulations, for the treatment of psychiatric disorders is not affecting its popularity.